Geneprodx us a clinical laboratory devoted to the molecular diagnostic of thyroid cancer. Geneprodx developed ThyroidPrint®, a test the will prevent 88% of unnecessary surgery practiced on patients with an undetermined diagnostic. ThyroidPrint® is the only genetic test for thyroid cancer that has been validated in two independent clinical trials: USA and Chile. Geneprodx is a spin-off from the Pontifical Catholic University of Chile and is the first chilean clinical laboratory to be accredited by the College of American Patologists (CAP). Visit our ThyroidPrint® website. There you may find all the information that patients and physicians need about this test.